Tabular data is at the heart of scientific analysis—whether in medicine, the social sciences, or even archaeology. Making it ...

NXP Semiconductors' Q2 results show early signs of recovery, but headline numbers remain tepid. Find out why NXPI stock is a ...

Miller/Howard warns megacap dominance may fade as buybacks prove unreliable. Discover why they’re leaning into steady ...

Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often than commonly thought, clinical trials are also uninformative.1 Artificial ...